Chen, H. H., AbouEzzeddine, O. F., Anstrom, K. J., Givertz, M. M., Bart, B. A., Felker, G. M., … Heart Failure Clinical Research Network, . (2013). Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail, 6(5), 1087–1094. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000347

Chen, Horng H., Omar F. AbouEzzeddine, Kevin J. Anstrom, Michael M. Givertz, Bradley A. Bart, G Michael Felker, Adrian F. Hernandez, et al. “Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.” Circ Heart Fail 6, no. 5 (September 1, 2013): 1087–94. https://doi.org/10.1161/CIRCHEARTFAILURE.113.000347.

Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, et al. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail. 2013 Sep 1;6(5):1087–94.

Chen, Horng H., et al. “Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.” Circ Heart Fail, vol. 6, no. 5, Sept. 2013, pp. 1087–94. Pubmed, doi:10.1161/CIRCHEARTFAILURE.113.000347.

Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, Hernandez AF, Lee KL, Braunwald E, Redfield MM, Heart Failure Clinical Research Network. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail. 2013 Sep 1;6(5):1087–1094.